You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Devices & Consumables

Insulin Syringes Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Insulin Syringes market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Insulin Syringes market segmented into
Insulin Pens
Insulin Pumps
Pen Needles
Insulin Syringes

Based on the end-use, the global Insulin Syringes market classified into
Patients/Homecare
Hospitals & Clinics

Based on geography, the global Insulin Syringes market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Animas Corporation (Johnson and Johnson)
Becton, Dickinson and Company
Biocon Limited
ELI Lilly and Company
Insulet Corporation
Medtronic PLC
Novo Nordisk A/S
Sanofi
Tandem Diabetes Care, Inc.
Ypsomed Holding AG
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL INSULIN SYRINGES INDUSTRY
2.1 Summary about Insulin Syringes Industry
2.2 Insulin Syringes Market Trends
2.2.1 Insulin Syringes Production & Consumption Trends
2.2.2 Insulin Syringes Demand Structure Trends
2.3 Insulin Syringes Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Insulin Pens
4.2.2 Insulin Pumps
4.2.3 Pen Needles
4.2.4 Insulin Syringes
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Patients/Homecare
4.3.2 Hospitals & Clinics
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Insulin Pens
5.2.2 Insulin Pumps
5.2.3 Pen Needles
5.2.4 Insulin Syringes
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Patients/Homecare
5.3.2 Hospitals & Clinics
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Insulin Pens
6.2.2 Insulin Pumps
6.2.3 Pen Needles
6.2.4 Insulin Syringes
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Patients/Homecare
6.3.2 Hospitals & Clinics
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Insulin Pens
7.2.2 Insulin Pumps
7.2.3 Pen Needles
7.2.4 Insulin Syringes
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Patients/Homecare
7.3.2 Hospitals & Clinics
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Insulin Pens
8.2.2 Insulin Pumps
8.2.3 Pen Needles
8.2.4 Insulin Syringes
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Patients/Homecare
8.3.2 Hospitals & Clinics
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Insulin Pens
9.2.2 Insulin Pumps
9.2.3 Pen Needles
9.2.4 Insulin Syringes
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Patients/Homecare
9.3.2 Hospitals & Clinics
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Animas Corporation (Johnson and Johnson)
10.1.2 Becton, Dickinson and Company
10.1.3 Biocon Limited
10.1.4 ELI Lilly and Company
10.1.5 Insulet Corporation
10.1.6 Medtronic PLC
10.1.7 Novo Nordisk A/S
10.1.8 Sanofi
10.1.9 Tandem Diabetes Care, Inc.
10.1.10 Ypsomed Holding AG
10.2 Insulin Syringes Sales Date of Major Players (2017-2020e)
10.2.1 Animas Corporation (Johnson and Johnson)
10.2.2 Becton, Dickinson and Company
10.2.3 Biocon Limited
10.2.4 ELI Lilly and Company
10.2.5 Insulet Corporation
10.2.6 Medtronic PLC
10.2.7 Novo Nordisk A/S
10.2.8 Sanofi
10.2.9 Tandem Diabetes Care, Inc.
10.2.10 Ypsomed Holding AG
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
  • FORMAT: PDF
  • PUBLISHED DATE: Jan, 2021
  • NO OF PAGES: 110